1,050% DIVIDEND: Mumbai-based pharma API maker woos Street with dividend payout - check out record date
Glenmark Life Sciences dividend news 2023: The stock of Glenmark Life Sciences - a Mumbai-based manufacturer of active pharmaceutical ingredients (APIs) - jumped almost five per cent on Friday, after the companys board declared a dividend of Rs 21 per equity share of face value Rs 2.
Glenmark Life Sciences dividend news 2023: Glenmark Life Sciences shares held on firmly to the green throughout a wild session on Dalal Street on Friday, a day after the Mumbai-based active pharma ingredients maker announced a dividend of Rs 21 per equity share of face value Rs 2. The Glenmark Life Sciences (GLS) stock gained by Rs 25 or 6.5 per cent to touch Rs 412.5 apiece during the session, before settling with a rise of 4.8 per cent at Rs 406 apiece.
A total of 40,000 Glenmark Life shares changed hands on the bourse on Friday, as against a daily average of 62,000 in the past two weeks, according to provisional exchange data.
Glenmark Life Sciences dividend: When is the record date?
The company had earlier announced a record date of March 24 for any such dividend.
What is a record date?
A record date determines the shareholders eligible to benefit from corporate action such as a dividend payout.
Glenmark Life Dividend: When will the dividend be paid?
Glenmark Life's board said, in a regulatory filing on Thursday, that the dividend will be paid to eligible shareholders on or after March 29.
Glernmark Life share price history
Glenmark Life shares have lost 12.8 per cent of their value in the past one year, a period in which the Nifty50 headline index has declined 1.5 per cent.
Catch highlights of the March 17 session here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.